Capstone Investment Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,000
Closed -$431K 2540
2023
Q4
$431K Hold
20,000
﹤0.01% 1414
2023
Q3
$372K Hold
20,000
﹤0.01% 1478
2023
Q2
$506K Hold
20,000
﹤0.01% 1157
2023
Q1
$518K Hold
20,000
﹤0.01% 997
2022
Q4
$473K Sell
20,000
-55,000
-73% -$1.48M ﹤0.01% 1145
2022
Q3
$1.9M Buy
75,000
+35,000
+88% +$1.23M 0.01% 777
2022
Q2
$1.33M Sell
40,000
-37,300
-48% -$1.58M 0.01% 915
2022
Q1
$5.58M Buy
+77,300
New +$5.57M 0.02% 663

Other funds holding TDOC

Capstone Investment Advisors's TDOC Position: Q4 2025 in Review

Capstone Investment Advisors sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 25,040 shares — an estimated $194K sold.

Capstone Investment Advisors first reported a position in TDOC in Q3 2020 and held it in 9 quarters. The position peaked at $21.5M in Q3 2020. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • Capstone Investment Advisors reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 25,040 Teladoc Health shares in Q4 2025, an estimated $194K.
  • Capstone Investment Advisors first reported a position in Teladoc Health in Q3 2020 and held it in 9 quarters.
  • Capstone Investment Advisors's Teladoc Health position peaked at $21.5M in Q3 2020.
  • 344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Capstone Investment Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.